Licensing deals might be pharma’s preferred mode of business development these days—perhaps even more so than outright acquisitions. Read on to find out which pharmaceutical companies have been using this strategy.
The post What Is In-Licensing? appeared first on Investing News Network.
Original Article: What Is In-Licensing?